As shown in Supplementary Figures S1A–D, tiliroside (25.0 and 50.0 mg/kg) markedly alleviated the TNBS-induced colitis, evidenced by increased survival rate, longer colon length, decreased MPO activity, and ameliorated pathological changes of colons. This evidence concerns the gene MPO and colitis.